Compugen to Present Anti-Tumor Activity and Safety Data of COM701, COM902 and Pembrolizumab Combination in Patients with Platinum Resistant Ovarian Cancer at SITC 2024
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
CGEN
Compugen Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2000
Get push alerts for CGEN
Full CGEN profile on Quantisnow Follow CGEN and get a push notification the moment its next story breaks.